Kingston Pharma LLC

Warning LetterOpen

United StatesIssued May 14, 2019

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Letter Details

Firm: Kingston Pharma LLC
Location: United States
FEI Number: N/A
Country: United States
Issue Date: May 14, 2019
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, Kingston Pharma LLC, a pharmaceutical drug manufacturer, received an FDA Warning Letter on May 14, 2019. While the specific violations cannot be detailed without access to the full letter text, the warning was issued under FDA's drug regulatory authority. Additional details regarding the nature of the violations and the specific issuing office are not available in the provided metadata.